Sndl SNDL

NASDAQ SNDL

$1.36 -0.04 (-3.21%)

As of: Sep 10, 2026 · 1:59 PM EDT

Key Stats

Market Cap349.66 Mn

P/E-17.09

P/S0.52

Div. Yield0.00

Revenue Growth (1y) (Qtr)-3.52

Add ratio to table…

About

SNDL Inc. is a Canadian company engaged in the retailing of wines, beers and spirits, the operation and support of corporate-owned, controlled and franchised retail cannabis stores, the manufacturing and distribution of cannabis products, and the provision of financial services through investments in the cannabis sector. The company generates revenue from liquor sales through its retail stores, cannabis retail sales via corporate-owned, franchised and partner outlets,…

The company generates revenue from liquor sales through its retail stores, cannabis retail sales via corporate-owned, franchised and partner outlets, cannabis operations including cultivation, processing and sale of cannabis products, and investment income from its deployment of capital in debt and equity securities and joint ventures.

The company operates through the following segments: liquor retail, cannabis retail, cannabis operations, and investments.

Liquor retail: This segment sells wines, beers and spirits through convenience-focused and destination/large-format stores under the Liquor Depot, Ace Liquor and Wine and Beyond banners.
Cannabis retail: This segment operates corporate-owned, controlled and franchised retail cannabis stores under the Value Buds and Spiritleaf banners, selling adult-use cannabis products and accessories.
Cannabis operations: This segment cultivates, processes, distributes and sells cannabis for medical and adult-use markets in Canada and for export, and provides proprietary cannabis processing services and product development.
Investments: This segment deploys capital into direct and indirect investments, partnerships and joint ventures such as SunStream Bancorp Inc., to generate financial returns and strategic exposure in the cannabis industry.

In the liquor retail industry, SNDL benefits from economies of scale due to its large store network and faces competition from grocery chains such as Real Canadian Superstore, Sobeys, Co-op, Costco and Safeway Canada, as well as convenience chains like 7-Eleven; its competitive advantages include visible store locations, strong product knowledge and centralized support functions.

The company serves individual consumers of liquor and cannabis, provincial buyers including the AGLC, OCS, BCLDB, MLL, SLGA, NBLC, NSLC, PEICMC, SQDC and NLC, as well as franchisees and licensed producers across Canada.

Investment Thesis

▲ Bull case

The exclusive Canadian commercialization and production agreement for the Jeter brand positions SNDL to capture premium market share in a segment that has demonstrated resilience despite broader softness. Early shipments and inventory build signal a committed rollout that can leverage existing distribution relationships with provincial boards, allowing the company to monetize a recognized U.S. brand in Canada where consumer loyalty is strong. By controlling end‑to‑end production, SNDL can improve margins through better cost control and product mix optimization, reducing reliance on third‑party manufacturers. The Jeter initiative also creates a cross‑border platform that can be leveraged for future U.S. expansion should federal reform progress, providing a strategic hedge against domestic market saturation. Management’s confidence in the brand’s long‑term upside suggests that the current valuation does not fully reflect this potential revenue stream.
International cannabis sales surged 94% year‑over‑year to $3.5 million, illustrating successful diversification beyond the challenged Canadian market. This growth indicates that SNDL’s export capabilities are gaining traction in jurisdictions with less competitive pressure and more favorable pricing dynamics. Expanding international footprint reduces reliance on domestic same‑store sales and provides a buffer against regional downturns. The ability to scale these sales with relatively low incremental cost could meaningfully improve overall revenue mix and contribute to gross profit stability. Investors may be underestimating the scalability of this avenue as a persistent growth driver.
The share repurchase program, with 4.5 million shares bought back in 2026, signals management’s belief that the stock is trading below intrinsic value and provides a direct mechanism to enhance shareholder returns. By retiring shares at current levels, SNDL can boost earnings per share even if absolute profits remain flat, creating a compounding effect on valuation. The willingness to prioritize buybacks over equity‑financed M&A suggests confidence in the underlying cash‑generating ability of the business. This capital allocation discipline can improve key per‑share metrics and support a higher trading multiple over time.
Retail margin expansion, with a 20‑basis‑point gain in liquor and a 100‑basis‑point gain in cannabis, demonstrates that operational execution is improving despite top‑line pressure. These gains stem from better promotional efficiency, pricing discipline, and optimized product mix, indicating that the company can extract more profit from each sale. Margin improvement acts as a lever to offset revenue declines and can drive operating leverage as sales stabilize. The fact that both retail segments show progress suggests that the underlying retail platform is becoming more efficient.
The profit enhancement plan targets more than $20 million of incremental operating income for the remainder of 2026, a figure that represents a meaningful uplift relative to current earnings levels. This initiative focuses on operational efficiencies, cost control, and commercial execution improvements that are already showing early results. If realized, the plan could shift the company from a marginal profitability stance to a more solid earnings base, providing a catalyst for re‑rating. Management’s track record of delivering cost savings (e.g., $2 million in additional G&A savings) lends credibility to achieving these targets.

The exclusive Canadian commercialization and production agreement for the Jeter brand positions SNDL to capture premium market share in a segment that has demonstrated resilience despite broader softness. Early shipments and inventory build signal a committed rollout that can leverage existing distribution relationships with provincial boards, allowing the company to monetize a recognized U.S. brand in Canada where consumer loyalty is strong. By controlling end‑to‑end production, SNDL can improve margins through better cost control and product mix optimization, reducing reliance on third‑party manufacturers. The Jeter initiative also creates a cross‑border platform that can be leveraged for future U.S. expansion should federal reform progress, providing a strategic hedge against domestic market saturation. Management’s confidence in the brand’s long‑term upside suggests that the current valuation does not fully reflect this potential revenue stream.
International cannabis sales surged 94% year‑over‑year to $3.5 million, illustrating successful diversification beyond the challenged Canadian market. This growth indicates that SNDL’s export capabilities are gaining traction in jurisdictions with less competitive pressure and more favorable pricing dynamics. Expanding international footprint reduces reliance on domestic same‑store sales and provides a buffer against regional downturns. The ability to scale these sales with relatively low incremental cost could meaningfully improve overall revenue mix and contribute to gross profit stability. Investors may be underestimating the scalability of this avenue as a persistent growth driver.
The share repurchase program, with 4.5 million shares bought back in 2026, signals management’s belief that the stock is trading below intrinsic value and provides a direct mechanism to enhance shareholder returns. By retiring shares at current levels, SNDL can boost earnings per share even if absolute profits remain flat, creating a compounding effect on valuation. The willingness to prioritize buybacks over equity‑financed M&A suggests confidence in the underlying cash‑generating ability of the business. This capital allocation discipline can improve key per‑share metrics and support a higher trading multiple over time.
Retail margin expansion, with a 20‑basis‑point gain in liquor and a 100‑basis‑point gain in cannabis, demonstrates that operational execution is improving despite top‑line pressure. These gains stem from better promotional efficiency, pricing discipline, and optimized product mix, indicating that the company can extract more profit from each sale. Margin improvement acts as a lever to offset revenue declines and can drive operating leverage as sales stabilize. The fact that both retail segments show progress suggests that the underlying retail platform is becoming more efficient.
The profit enhancement plan targets more than $20 million of incremental operating income for the remainder of 2026, a figure that represents a meaningful uplift relative to current earnings levels. This initiative focuses on operational efficiencies, cost control, and commercial execution improvements that are already showing early results. If realized, the plan could shift the company from a marginal profitability stance to a more solid earnings base, providing a catalyst for re‑rating. Management’s track record of delivering cost savings (e.g., $2 million in additional G&A savings) lends credibility to achieving these targets.

▼ Bear case

Same‑store sales declined 6.1% in liquor and 2.5% in cannabis, indicating that core store productivity is weakening despite new store openings. The persistent negative trend suggests that market saturation, competitive intensity, and macroeconomic pressures are eroding the productivity of the existing base. Unless the company can reverse this trajectory, reliance on new store openings to flatter top‑line growth will become increasingly costly and less effective. The deterioration in comparable sales is a leading indicator of future revenue challenges that margin improvements alone may not offset.
Cannabis operations revenue fell 14% year‑over‑year, driven largely by destocking and a sharp reduction in B2B contract sales, which dropped from $9 million to $4.5 million. This volatility in the wholesale channel exposes the segment to timing risks and the inventory cycles of third‑party producers. The dependence on uneven contract flows makes forecasting difficult and can lead to periods of under‑utilization of manufacturing capacity. Such instability hampers the ability to achieve consistent operating profitability in this division.
Gross margin in the cannabis operations segment deteriorated by seven percentage points to 19.7%, reflecting inventory adjustments, under‑absorption, and manufacturing inefficiencies tied to the Jeter launch. Margin compression at this level directly impacts gross profit and limits the cash flow available for reinvestment or debt service. The fact that the decline is isolated to cannabis operations while retail margins improved highlights a structural weakness in the upstream side of the business that may persist until production processes are fully optimized.
Free cash flow was negative $7.6 million for the quarter, a deterioration of $6.5 million versus the prior year, driven by working capital increases in cannabis, higher capex, and elevated lease costs. Persistent negative free cash flow restricts the company’s flexibility to fund strategic initiatives without relying on external financing or further eroding cash reserves. The trend suggests that operational cash generation is insufficient to cover both maintenance and growth expenditures, raising concerns about long‑term financial sustainability.
Working capital pressures in cannabis operations stem from inventory buildup related to the Jeter launch and slower receivables turnover, indicating that the company may be overextending resources on new product introductions. Elevated inventory levels increase carrying costs and risk of obsolescence if demand does not materialize as expected. This dynamic can tie up cash that would otherwise be used for debt reduction or shareholder returns, creating a drag on overall financial health.

Same‑store sales declined 6.1% in liquor and 2.5% in cannabis, indicating that core store productivity is weakening despite new store openings. The persistent negative trend suggests that market saturation, competitive intensity, and macroeconomic pressures are eroding the productivity of the existing base. Unless the company can reverse this trajectory, reliance on new store openings to flatter top‑line growth will become increasingly costly and less effective. The deterioration in comparable sales is a leading indicator of future revenue challenges that margin improvements alone may not offset.
Cannabis operations revenue fell 14% year‑over‑year, driven largely by destocking and a sharp reduction in B2B contract sales, which dropped from $9 million to $4.5 million. This volatility in the wholesale channel exposes the segment to timing risks and the inventory cycles of third‑party producers. The dependence on uneven contract flows makes forecasting difficult and can lead to periods of under‑utilization of manufacturing capacity. Such instability hampers the ability to achieve consistent operating profitability in this division.
Gross margin in the cannabis operations segment deteriorated by seven percentage points to 19.7%, reflecting inventory adjustments, under‑absorption, and manufacturing inefficiencies tied to the Jeter launch. Margin compression at this level directly impacts gross profit and limits the cash flow available for reinvestment or debt service. The fact that the decline is isolated to cannabis operations while retail margins improved highlights a structural weakness in the upstream side of the business that may persist until production processes are fully optimized.
Free cash flow was negative $7.6 million for the quarter, a deterioration of $6.5 million versus the prior year, driven by working capital increases in cannabis, higher capex, and elevated lease costs. Persistent negative free cash flow restricts the company’s flexibility to fund strategic initiatives without relying on external financing or further eroding cash reserves. The trend suggests that operational cash generation is insufficient to cover both maintenance and growth expenditures, raising concerns about long‑term financial sustainability.
Working capital pressures in cannabis operations stem from inventory buildup related to the Jeter launch and slower receivables turnover, indicating that the company may be overextending resources on new product introductions. Elevated inventory levels increase carrying costs and risk of obsolescence if demand does not materialize as expected. This dynamic can tie up cash that would otherwise be used for debt reduction or shareholder returns, creating a drag on overall financial health.

Peer group

Peer Comparison

Companies in the Cannabis

S.No.	Ticker	Company	match	Market Cap	P/E	P/S	Total Debt (Qtr)
1	CURLF	Curaleaf Holdings, Inc.	primary	2.65 Bn	-22.33	2.02	611.54 Mn
2	TRLV	Trulieve Cannabis Corp.	primary	2.28 Bn	-4.82	2.00	98.73 Mn
3	GTBIF	Green Thumb Industries Inc.	primary	1.68 Bn	13.36	1.39	306.74 Mn
4	CRON	Cronos Group Inc.	primary	1.18 Bn	14.91	4.99	-
5	GLAS	Glass House Brands Inc.	primary	0.67 Bn	-13.17	4.40	70.14 Mn
6	VREOF	Vireo Growth Inc.	primary	0.55 Bn	-6.37	1.07	298.80 Mn
7	TLRY	Tilray Brands, Inc.	primary	0.47 Bn	-4.84	0.51	147.36 Mn
8	VRNO	Verano Holdings Corp.	primary	0.44 Bn	-1.70	0.53	403.16 Mn

Sndl SNDL

About

Investment Thesis

Peer Comparison

Create an account

Sign In

Reset Password